Thrombosis / rasvumus

Polycosanols from Ericerus pela wax

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The present invention relates generally to a method for the generation of a composition of matter comprised of a unique profile of primary aliphatic alcohols, having 24 to 30 carbon atoms, from a novel natural source--a wax secreted by the Chinese wax soft scale insect,

Polycosanols from Ericerus pela wax

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The present invention relates generally to a method for the generation of a composition of matter comprised of a unique profile of primary aliphatic alcohols, having 24 to 30 carbon atoms, from a novel natural source--a wax secreted by the Chinese wax soft scale insect,

Polycosanols from Ericerus pela wax

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The present invention relates generally to a method for the generation of a composition of matter comprised of a unique profile of primary aliphatic alcohols, having 24 to 30 carbon atoms, from a novel natural source--a wax secreted by the Chinese wax soft scale insect,

Polycosanols from ericerus pela wax

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The present invention relates generally to a method for the generation of a composition of matter comprised of a unique profile of primary aliphatic alcohols, having 24 to 30 carbon atoms, from a novel natural source--a wax secreted by the Chinese wax soft scale insect,

Substances KF-1040 and process for producing of the same

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The present invention relates to novel KF-1040 substance having an inhibitory activity for lipid metabolism as well as to a process for producing such substance. PRIOR ARTS There have been known anti-obesity drugs and drugs for hyperlipidemia. For example, centrally acting

Pyrazolopyridine compound and processes for preparation thereof

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

The present invention relates to novel pyrazolopyridine compound and a pharmaceutically acceptable salt thereof. More particularly, it relates to novel pyrazolopyridine compound and a pharmaceutically acceptable salt thereof, which are adenosine antagonists and possess various pharmaceutical actions

Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF INVENTION The use of a combination of non .beta.-oxidizable fatty acid entities and a protein material has shown surprising synergistic effects. The present invention concerns a composition prepared from a combination of compounds comprising non .beta.-oxidizable fatty acid entities and a

Cardioprotective phosphonates and malonates

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION This invention relates to pyridoxine phosphonate analogues, to pyridoxine malonate analogues, to their preparation, to pharmaceutical compositions thereof, and to treatments for cardiovascular and related diseases, for example, hypertrophy, hypertension, congestive heart

Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

BACKGROUND OF THE INVENTION Serotonin is a vasoconstrictor and neurotransmitter present in the brain, intestinal tissue and blood platelets. Regulation of the binding of serotonin can provide a method of treatment and prevention of a variety of illnesses including central nervous disorders,

Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION This invention relates to novel substituted benzimidazol-2-ones. More particularly, the compounds of the present invention modulate the binding of the peptide hormone vasopressin and neuropeptide Y to their respective receptors and are therefore useful for treating conditions

Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The present invention relates to compounds which modulate one or more of ERalpha/beta and GPR30 receptors, to pharmaceutical compositions based upon those compounds and to methods of treating disease states and conditions mediated through these receptors and related methods

Compounds for binding to ER.alpha./.beta. and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The present invention relates to compounds which modulate one or more of ERalpha/beta and GPR30 receptors, to pharmaceutical compositions based upon those compounds and to methods of treating disease states and conditions mediated through these receptors and related methods

Human G-protein coupled receptor

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to a G-protein coupled receptor

Antibodies immunospecific for a novel human G-protein coupled receptor family

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to a G-protein coupled receptor

Pyrazolopyridine compounds which have useful pharmaceutical utility

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

The present invention relates to novel pyrazolopyridine compound and a pharmaceutically acceptable salt thereof. More particularly, it relates to novel pyrazolopyridine compound and a pharmaceutically acceptable salt thereof, which are adenosine antagonists and posses various pharmaceutical actions

thrombosis/rasvumus

Polycosanols from Ericerus pela wax

Polycosanols from Ericerus pela wax

Polycosanols from Ericerus pela wax

Polycosanols from ericerus pela wax

Substances KF-1040 and process for producing of the same

Pyrazolopyridine compound and processes for preparation thereof

Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities

Cardioprotective phosphonates and malonates

Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines

Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators

Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof

Compounds for binding to ER.alpha./.beta. and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof

Human G-protein coupled receptor

Antibodies immunospecific for a novel human G-protein coupled receptor family

Pyrazolopyridine compounds which have useful pharmaceutical utility

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus